Market Tracker

10/24 2:49pm ET
12.10
Real-Time Quote
 -0.08 / -0.66%
Today’s Change
6.92
Today|||52-Week Range
18.80
+7.17%
Year-to-Date

Today’s Trading

Previous close12.18
Today’s open12.08
Day’s range11.96 - 12.40
Volume84,643
Average volume (3 months)296,173
Market cap$414.1M
Dividend yield--
Data as of 2:34pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)+12.58%
Earnings growth (this year)-58.27%
Earnings growth (next 5 years)+85.00%
Revenue growth (last year)-73.43%
P/E ratioNM
Price/Sales201.53
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ZFGNZafgen Inc+0.22+1.22%
IMDZImmune Design Corp+0.62+2.48%
SCLNSciClone Pharmaceuti...-0.01-0.13%
DVAXDynavax Technologies...+0.08+5.23%
Data as of 2:48pm ET, 10/24/2014

Financials

Next reporting dateNovember 6, 2014
EPS forecast (this quarter)-$0.60
Annual revenue (last year)$1.6M
Annual profit (last year)-$39.8M
Net profit margin-2,487.25%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Gregory A. Demopulos
Senior Director-
Finance
David R. Toll
Corporate headquarters
Seattle, Washington

Forecasts